Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

Randomized, phase 2 trial comparing low-dose cytarabine with or without volasertib in AML patients not suitable for intensive induction therapy.

Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J.

Blood. 2014 Jul 8. pii: blood-2014-03-560557. [Epub ahead of print]

PMID:
25006120
[PubMed - as supplied by publisher]
2.

A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).

Van Obbergh F, Michaux L, Maertens J, Schoemans H, Vandenberghe P.

Cancer Genet. 2014 May 4. pii: S2210-7762(14)00086-6. doi: 10.1016/j.cancergen.2014.04.009. [Epub ahead of print] No abstract available.

PMID:
24972931
[PubMed - as supplied by publisher]
3.

Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013.

Eyckmans T, Wollants E, Janssens A, Schoemans H, Lagrou K, Wauters J, Maertens J.

Emerg Infect Dis. 2014 May;20(5):913-5. doi: 10.3201/eid2005.131766. No abstract available.

PMID:
24751368
[PubMed - in process]
Free PMC Article
4.

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease.

Maertens J, Cornely OA, Ullmann AJ, Heinz WJ, Krishna G, Patino H, Caceres M, Kartsonis N, Waskin H, Robertson MN.

Antimicrob Agents Chemother. 2014 Jul;58(7):3610-3617. Epub 2014 Apr 14.

PMID:
24733463
[PubMed - as supplied by publisher]
5.

One step DNA assembly for combinatorial metabolic engineering.

Coussement P, Maertens J, Beauprez J, Van Bellegem W, De Mey M.

Metab Eng. 2014 May;23:70-7. doi: 10.1016/j.ymben.2014.02.012. Epub 2014 Mar 2.

PMID:
24594279
[PubMed - in process]
6.

Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.

Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, Löffler J, Maertens JA, Bell AS, Inforzato A, Barbati E, Almeida B, Santos e Sousa P, Barbui A, Potenza L, Caira M, Rodrigues F, Salvatori G, Pagano L, Luppi M, Mantovani A, Velardi A, Romani L, Carvalho A.

N Engl J Med. 2014 Jan 30;370(5):421-32. doi: 10.1056/NEJMoa1211161.

PMID:
24476432
[PubMed - indexed for MEDLINE]
7.

Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Yeshurun M, Labopin M, Blaise D, Cornelissen JJ, Sengeloev H, Vindelov L, Kuball J, Chevallier P, Craddock C, Socie G, Bilger K, Schouten HC, Fegueux N, Goker H, Maertens J, Bunjes D, Arnold R, Nagler A, Mohty M.

Cancer. 2014 Mar 15;120(6):855-63. doi: 10.1002/cncr.28498. Epub 2013 Dec 10.

PMID:
24338939
[PubMed - indexed for MEDLINE]
8.

The Eagle-like effect of echinocandins: what's in a name?

Vanstraelen K, Lagrou K, Maertens J, Wauters J, Willems L, Spriet I.

Expert Rev Anti Infect Ther. 2013 Nov;11(11):1179-91. doi: 10.1586/14787210.2013.841543. Epub 2013 Oct 18. Review.

PMID:
24134556
[PubMed - indexed for MEDLINE]
9.

Clinical evidence for orphan medicinal products-a cause for concern?

Picavet E, Cassiman D, Hollak CE, Maertens JA, Simoens S.

Orphanet J Rare Dis. 2013 Oct 16;8:164. doi: 10.1186/1750-1172-8-164.

PMID:
24131572
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.

Vermeulen E, Maertens J, Meersseman P, Saegeman V, Dupont L, Lagrou K.

Clin Microbiol Infect. 2014 May;20(5):O333-5. doi: 10.1111/1469-0691.12394. Epub 2013 Nov 4.

PMID:
24102876
[PubMed - in process]
11.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ.

J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23.

PMID:
24062400
[PubMed - indexed for MEDLINE]
12.

Meeting the challenge of invasive fungal infections: part 2.

Maertens J, Lyon S.

Future Microbiol. 2013 Oct;8(10):1245-7. doi: 10.2217/fmb.13.97.

PMID:
24059915
[PubMed - indexed for MEDLINE]
Free Article
13.

Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients.

Potenza L, Vallerini D, Barozzi P, Riva G, Forghieri F, Beauvais A, Beau R, Candoni A, Maertens J, Rossi G, Morselli M, Zanetti E, Quadrelli C, Codeluppi M, Guaraldi G, Pagano L, Caira M, Del Giovane C, Maccaferri M, Stefani A, Morandi U, Tazzioli G, Girardis M, Delia M, Specchia G, Longo G, Marasca R, Narni F, Merli F, Imovilli A, Apolone G, Carvalho A, Comoli P, Romani L, Latgè JP, Luppi M.

PLoS One. 2013 Sep 4;8(9):e74326. doi: 10.1371/journal.pone.0074326. eCollection 2013.

PMID:
24023936
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Meeting the challenge of invasive fungal infections: part 1.

Maertens J, Lyon S.

Future Microbiol. 2013 Sep;8(9):1063-5. doi: 10.2217/fmb.13.96.

PMID:
24020734
[PubMed - indexed for MEDLINE]
Free Article
15.

Unraveling the Leloir pathway of Bifidobacterium bifidum: significance of the uridylyltransferases.

De Bruyn F, Beauprez J, Maertens J, Soetaert W, De Mey M.

Appl Environ Microbiol. 2013 Nov;79(22):7028-35. doi: 10.1128/AEM.02460-13. Epub 2013 Sep 6.

PMID:
24014529
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation.

Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socié G, Tischer J, Oneto R, Passweg J, Marsh J.

Haematologica. 2013 Nov;98(11):1804-9. doi: 10.3324/haematol.2013.091074. Epub 2013 Jul 26.

PMID:
23894010
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

Am J Hematol. 2013 Dec;88(12):990-6. doi: 10.1002/ajh.23552. Epub 2013 Sep 30.

PMID:
23873823
[PubMed - indexed for MEDLINE]
18.

The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.

Schlenk RF, Taskesen E, van Norden Y, Krauter J, Ganser A, Bullinger L, Gaidzik VI, Paschka P, Corbacioglu A, Göhring G, Kündgen A, Held G, Götze K, Vellenga E, Kuball J, Schanz U, Passweg J, Pabst T, Maertens J, Ossenkoppele GJ, Delwel R, Döhner H, Cornelissen JJ, Döhner K, Löwenberg B.

Blood. 2013 Aug 29;122(9):1576-82. doi: 10.1182/blood-2013-05-503847. Epub 2013 Jul 17.

PMID:
23863898
[PubMed - indexed for MEDLINE]
19.

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.

Robinson SP, Canals C, Luang JJ, Tilly H, Crawley C, Cahn JY, Pohlreich D, Le Gouill S, Gilleece M, Milpied N, Attal M, Biron P, Maury S, Rambaldi A, Maertens J, Capria S, Colombat P, Montoto S, Sureda A.

Bone Marrow Transplant. 2013 Nov;48(11):1409-14. doi: 10.1038/bmt.2013.83. Epub 2013 Jun 17.

PMID:
23771004
[PubMed - in process]
20.

A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.

Graux C, Sonet A, Maertens J, Duyster J, Greiner J, Chalandon Y, Martinelli G, Hess D, Heim D, Giles FJ, Kelly KR, Gianella-Borradori A, Longerey B, Asatiani E, Rejeb N, Ottmann OG.

Leuk Res. 2013 Sep;37(9):1100-6. doi: 10.1016/j.leukres.2013.04.025. Epub 2013 Jun 5.

PMID:
23746966
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk